ReviewPharmaceutics2022
Topically Applied Resiquimod versus Imiquimod as a Potential Adjuvant in Melanoma Treatment.
Supreeda Tambunlertchai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this paperpooled itcites it